My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 913

    1.

    Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy.

    Marcellin P, Boyer N, Gervais A, Martinot M, Pouteau M, Castelnau C, Kilani A, Areias J, Auperin A, Benhamou JP, Degott C, Erlinger S.

    Ann Intern Med. 1997 Nov 15;127(10):875-81.PMID: 9382365 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Long term histological improvement and clearance of intrahepatic hepatitis C virus RNA following sustained response to interferon-ribavirin combination therapy in liver transplanted patients with hepatitis C virus recurrence.

    Bizollon T, Ahmed SN, Radenne S, Chevallier M, Chevallier P, Parvaz P, Guichard S, Ducerf C, Baulieux J, Zoulim F, Trepo C.

    Gut. 2003 Feb;52(2):283-7.PMID: 12524414 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Persistent hepatitis C viremia predicts late relapse after sustained response to interferon-alpha in chronic hepatitis C. TriVeneto Viral Hepatitis Group.

    Chemello L, Cavalletto L, Casarin C, Bonetti P, Bernardinello E, Pontisso P, Donada C, Belussi F, Martinelli S, Alberti A.

    Ann Intern Med. 1996 Jun 15;124(12):1058-60.PMID: 8633819 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Hepatic hepatitis C virus RNA as a predictor of a long-term response to interferon-alpha therapy.

    Shindo M, Arai K, Sokawa Y, Okuno T.

    Ann Intern Med. 1995 Apr 15;122(8):586-91.PMID: 7887552 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Complete eradication of hepatitis C virus after interferon treatment for chronic hepatitis C.

    De Mitri MS, Morsica G, Chen CH, Mele L, Baccarini P, Chianese R, Piccinini A, Lazzarin A, Pisi E.

    Ital J Gastroenterol Hepatol. 1997 Jun;29(3):255-61.PMID: 9646218 [PubMed - indexed for MEDLINE]Related articles

    6.

    Long-term follow-up of chronic hepatitis C patients with sustained virological response to alpha-interferon.

    Reichard O, Glaumann H, Frydén A, Norkrans G, Wejstål R, Weiland O.

    J Hepatol. 1999 May;30(5):783-7.PMID: 10365802 [PubMed - indexed for MEDLINE]Related articles

    7.

    Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: results of an international randomized controlled trial. Clinical Advisory Group for the Hepatitis C Comparative Study.

    Farrell GC, Bacon BR, Goldin RD.

    Hepatology. 1998 Apr;27(4):1121-7.PMID: 9537453 [PubMed - indexed for MEDLINE]Related articles

    8.

    Combination treatment of interferon alpha-2b and ribavirin in comparison to interferon monotherapy in treatment of chronic hepatitis C genotype 4 patients.

    el-Zayadi A, Selim O, Haddad S, Simmonds P, Hamdy H, Badran HM, Shawky S.

    Ital J Gastroenterol Hepatol. 1999 Aug-Sep;31(6):472-5.PMID: 10575565 [PubMed - indexed for MEDLINE]Related articles

    9.

    10-Year follow-up after interferon-alpha therapy for chronic hepatitis C.

    Lau DT, Kleiner DE, Ghany MG, Park Y, Schmid P, Hoofnagle JH.

    Hepatology. 1998 Oct;28(4):1121-7.PMID: 9755252 [PubMed - indexed for MEDLINE]Related articles

    10.

    Durability of serological remission in chronic hepatitis C treated with interferon-alpha-2B.

    Sim H, Yim C, Krajden M, Heathcote J.

    Am J Gastroenterol. 1998 Jan;93(1):39-43.PMID: 9448171 [PubMed - indexed for MEDLINE]Related articles

    11.

    Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group.

    Davis GL, Esteban-Mur R, Rustgi V, Hoefs J, Gordon SC, Trepo C, Shiffman ML, Zeuzem S, Craxi A, Ling MH, Albrecht J.

    N Engl J Med. 1998 Nov 19;339(21):1493-9.PMID: 9819447 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Long-term responders without eradication of hepatitis C virus after interferon therapy: characterization of clinical profiles and incidence of hepatocellular carcinoma.

    Yabuuchi I, Imai Y, Kawata S, Tamura S, Noda S, Inada M, Maeda Y, Shirai Y, Fukuzaki T, Kaji I, Ishikawa H, Matsuda Y, Nishikawa M, Seki K, Matsuzawa Y.

    Liver. 2000 Jul;20(4):290-5.PMID: 10959807 [PubMed - indexed for MEDLINE]Related articles

    13.

    Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children.

    Czerwionka-Szaflarska M, Chrobot A, Szaflarska-Szczepanik A.

    Med Sci Monit. 2000 Sep-Oct;6(5):964-70.PMID: 11208439 [PubMed - indexed for MEDLINE]Related articles

    14.

    Efficacy of interferon treatment for patients with chronic hepatitis C: comparison of response in cirrhotics, fibrotics, or nonfibrotics.

    Everson GT, Jensen DM, Craig JR, van Leeuwen DJ, Bain VG, Ehrinpreis MN, Albert D, Joh T, Witt K.

    Hepatology. 1999 Jul;30(1):271-6.PMID: 10385666 [PubMed - indexed for MEDLINE]Related articles

    15.

    Comparison of thrice weekly vs daily human leucocyte interferon-alpha therapy for chronic hepatitis C. TVVH Study Group.

    Chemello L, Cavalletto L, Bernardinello E, Boccato S, Casarin P, Cavinato F, Urban F, Pontisso P, Cecchetto A, Gatta A, Alberti A.

    J Viral Hepat. 1999 Jul;6(4):321-7.PMID: 10607247 [PubMed - indexed for MEDLINE]Related articles

    16.

    Clinical significance of hepatic HCV RNA in patients with chronic hepatitis C demonstrating long-term sustained response to interferon-alpha therapy.

    Larghi A, Tagger A, Crosignani A, Ribero ML, Bruno S, Portera G, Battezzati PM, Maggioni M, Fasola M, Zuin M, Podda M.

    J Med Virol. 1998 May;55(1):7-11.PMID: 9580879 [PubMed - indexed for MEDLINE]Related articles

    17.

    Alpha-interferon therapy in chronic hepatitis due to active dual infection with hepatitis B and C viruses.

    Guptan RC, Thakur V, Raina V, Sarin SK.

    J Gastroenterol Hepatol. 1999 Sep;14(9):893-8.PMID: 10535471 [PubMed - indexed for MEDLINE]Related articles

    18.

    Virological and histological responses to one year alpha-interferon-2a in hemodialyzed patients with chronic hepatitis C.

    Hanrotel C, Toupance O, Lavaud S, Thiefin G, Brodard V, Ingrand D, Diebold MD, Wynckel A, Chanard J.

    Nephron. 2001 Jun;88(2):120-6.PMID: 11399913 [PubMed - indexed for MEDLINE]Related articles

    19.

    Long-term clinical and virological outcomes of chronic hepatitis C after successful interferon therapy.

    Tsuda N, Yuki N, Mochizuki K, Nagaoka T, Yamashiro M, Omura M, Hikiji K, Kato M.

    J Med Virol. 2004 Nov;74(3):406-13.PMID: 15368524 [PubMed - indexed for MEDLINE]Related articles

    20.

    Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized study.

    Samuel D, Bizollon T, Feray C, Roche B, Ahmed SN, Lemonnier C, Cohard M, Reynes M, Chevallier M, Ducerf C, Baulieux J, Geffner M, Albrecht JK, Bismuth H, Trepo C.

    Gastroenterology. 2003 Mar;124(3):642-50.PMID: 12612903 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity